However, because the number of new ODs on the market grew steadily in the study period, the percentage of ODs that experienced a shortage had a decreasing trend since the maximum of 5.3 % in 2011.
← all excerpts
Quantifying the persisting orphan-drug shortage public health crisis in the United States.
1
—
—